Stonefly news

 
2/1/08 - Stonefly Wins Three-Year Agency-of-Record Assignment for Leading Global Medical Food Manufacturer
Professional Assignment Includes 14 Brands

Columbus, Ohio – February 1, 2008– Stonefly Communications Group, an inVentiv Health company (NASDAQ:VTIV) and a purpose-driven, patient-focused healthcare advertising agency, was named professional agency of record for Leading Global Medical Food Manufacturer, which encompasses over 14 brands. The details of the contract were not disclosed.   

As agency of record, Stonefly will be responsible for strategic marketing and creative brand development for all of the products in the assigned franchise.  

"Stonefly has been providing marketing support for several of these products since last year, and we are thrilled to now be taking on an expanded role as agency of record for this important portfolio of products," said John Racik, president of Stonefly Communications Group.  "Because our company is built upon a common belief in supporting patients' health and wellness, I cannot think of a client who would be a more fitting partner for Stonefly than this global leader in nutrition. Their track record for providing exceptional nutrition to people of all ages is unmatched in the industry."

Client sources said, "Stonefly won this account based on their impressive experience in marketing healthcare products and a great understanding of how to successfully communicate to healthcare professionals.  We look forward to partnering with them to create effective and memorable marketing campaigns for our products."

About Stonefly Communications Group

Stonefly Communications Group is a purpose-driven, patient-focused healthcare advertising agency dedicated to redefining success for its clients around the world. With a promise to continually innovate, Stonefly's client advisors and creative champions develop actionable strategies that engage audiences with bold strategic, tactical and creative solutions. For more information on Stonefly, visit www.stoneflygroup.com

About inVentiv Health

inVentiv Health (NASDAQ: VTIV) is the leading provider of commercialization and complementary services to the healthcare industry globally. inVentiv delivers its customized clinical, sales, marketing and communications solutions through its four core business segments: inVentiv Clinical, inVentiv Communications, inVentiv Commercial and inVentiv Patient Outcomes. inVentiv Health's client roster is composed of more than 275 leading pharmaceutical, biotech, life sciences and healthcare payor companies, including the top 20 global pharmaceutical manufacturers. For more information, visit www.inventivhealth.com.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause inVentiv Health's performance to differ materially. Such risks include, without limitation: changes in trends in the pharmaceutical industry or in pharmaceutical outsourcing; our ability to compete successfully with other services in the market; our ability to maintain large client contracts or to enter into new contracts; and, our ability to operate successfully in new lines of business. Readers of this press release are referred to documents filed from time to time by inVentiv Health, Inc. with the Securities and Exchange Commission for further discussion of these and other factors.